252 related articles for article (PubMed ID: 31774630)
1. Split-sample comparison of urothelial cells in ThinPrep and cytospin preparations in urinary cytology: Do we need to adjust The Paris System for Reporting Urinary Cytology criteria?
Richardson CJ; Pambuccian SE; Barkan GA
Cancer Cytopathol; 2020 Feb; 128(2):119-125. PubMed ID: 31774630
[TBL] [Abstract][Full Text] [Related]
2. Quantitative cytomorphological comparison of SurePath and ThinPrep liquid-based cytology using high-grade urothelial carcinoma cells.
Okuda C; Kyotake A; Nakamura A; Itoh T; Kamoshida S; Ohsaki H
Cytopathology; 2021 Sep; 32(5):654-659. PubMed ID: 34033150
[TBL] [Abstract][Full Text] [Related]
3. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value below 0.7 for positive for high-grade urothelial carcinoma and suspicious for high-grade urothelial carcinoma in urine cytology specimens.
McIntire PJ; Snow JT; Elsoukkary SS; Soong L; Sweeney J; Robinson BD; Siddiqui MT
Cancer Cytopathol; 2019 Feb; 127(2):120-124. PubMed ID: 30395388
[TBL] [Abstract][Full Text] [Related]
4. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
Vlajnic T; Gut A; Savic S; Bubendorf L
J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
[TBL] [Abstract][Full Text] [Related]
5. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
6. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology.
Cowan ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842
[TBL] [Abstract][Full Text] [Related]
7. Digital image analysis supports a nuclear-to-cytoplasmic ratio cutoff value of 0.5 for atypical urothelial cells.
Hang JF; Charu V; Zhang ML; VandenBussche CJ
Cancer Cytopathol; 2017 Sep; 125(9):710-716. PubMed ID: 28581671
[TBL] [Abstract][Full Text] [Related]
8. Cyto-histo correlations of plasmacytoid and micropapillary variants of high-grade urothelial carcinoma: do they fit well in The Paris System for reporting urinary cytology?
Suo L; Vega I; Thrall M
J Am Soc Cytopathol; 2021; 10(1):20-24. PubMed ID: 32620533
[TBL] [Abstract][Full Text] [Related]
9. Cytologic evaluation of upper urinary tract specimens: An institutional retrospective study using The Paris System for Reporting Urine Cytology second edition with histopathologic follow-up.
Khajir G; Sun T; Wang H; Sprenkle PC; Adeniran AJ; Cai G; Levi AW
Cytopathology; 2024 Mar; 35(2):235-241. PubMed ID: 37916579
[TBL] [Abstract][Full Text] [Related]
10. Implementation of The Paris System for Reporting Urine Cytology improves diagnostic accuracy of selective upper urinary tract cytology.
Miyai K; Nakayama M; Minabe S; Ogata S; Ito K; Matsukuma S
Cancer Cytopathol; 2024 Apr; 132(4):242-249. PubMed ID: 38294961
[TBL] [Abstract][Full Text] [Related]
11. Comparison of conventional and liquid-based cytology using The Paris System for Reporting Urinary Cytology.
Goutas D; Savvidou K; Vrettou K; Meletis E; Levis P; Constantinides C; Lazaris AC; Mikou P
Cytopathology; 2021 Nov; 32(6):795-801. PubMed ID: 34289188
[TBL] [Abstract][Full Text] [Related]
12. The utility of upper urinary tract urine cytology before and after application of the Paris system.
Simon CT; Skala SL; Magers MJ; Weizer A; Kaffenberger SD; Chinnaiyan AM; Spratt DE; Montgomery J; Mehra R; Lew M
Diagn Cytopathol; 2019 May; 47(5):421-427. PubMed ID: 30569543
[TBL] [Abstract][Full Text] [Related]
13. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
[TBL] [Abstract][Full Text] [Related]
14. An institutional experience evaluating hTERT immunostaining in 100 consecutive ThinPrep urine specimens.
Xing J; Han M; Monaco SE; Dhir R; Roy S; Pantanowitz L
J Am Soc Cytopathol; 2021; 10(1):88-93. PubMed ID: 32354607
[TBL] [Abstract][Full Text] [Related]
15. The Paris System "atypical urothelial cells" category: can the current criteria be improved?
Vosoughi A; Ordobazari A; Lora Gonzalez MA; Guido LP; Skiba M; Campuzano-Zuluaga G; Kryvenko ON; Gomez-Fernandez C; Garcia-Buitrago M; Jorda M
J Am Soc Cytopathol; 2021; 10(1):3-8. PubMed ID: 32732113
[TBL] [Abstract][Full Text] [Related]
16. Modification of The Paris System for urinary tract washing specimens using diagnostic cytological features.
Suh J; Go H; Sung C; Baek S; Hwang H; Jeong S; Cho Y
Cytopathology; 2017 Dec; 28(6):516-523. PubMed ID: 28816366
[TBL] [Abstract][Full Text] [Related]
17. Cyto-histo correlation and false-negative urine: Before and after the Paris system for reporting urinary cytology.
Yuan L; Gero M; Zia S; Aryal SC; Shetty S; Reynolds JP
Diagn Cytopathol; 2022 Aug; 50(8):404-410. PubMed ID: 35652594
[TBL] [Abstract][Full Text] [Related]
18. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology.
Straccia P; Bizzarro T; Fadda G; Pierconti F
Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867
[TBL] [Abstract][Full Text] [Related]
19. The Paris System for urine cytology in upper tract urothelial specimens: A comparative analysis with biopsy and surgical resection.
Zheng X; Si Q; Du D; Harshan M; Zhang Z; Haines K; Shi W; Chhieng DC
Cytopathology; 2018 Apr; 29(2):184-188. PubMed ID: 29251368
[TBL] [Abstract][Full Text] [Related]
20. Experience on the use of The Paris System for Reporting Urinary Cytopathology: review of the published literature.
Pastorello RG; Barkan GA; Saieg M
J Am Soc Cytopathol; 2021; 10(1):79-87. PubMed ID: 33160893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]